Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,728 | -33,443 | -16,379 | -72,282 | -52,949 |
| Depreciation Amortization | 794 | 476 | 252 | 678 | 435 |
| Accounts receivable | -632 | -1,043 | 387 | -612 | -2,962 |
| Accounts payable and accrued liabilities | 1,078 | 1,765 | -313 | -482 | -1,195 |
| Other Working Capital | -3,010 | -887 | 946 | 5,413 | 5,179 |
| Other Operating Activity | 9,187 | 5,261 | 3,163 | 13,619 | 15,235 |
| Operating Cash Flow | $-47,311 | $-27,871 | $-11,944 | $-53,666 | $-36,257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -286 | -19 | -19 | -367 | -269 |
| Investing Cash Flow | $-286 | $-19 | $-19 | $-367 | $-269 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 31,600 | 20,600 | N/A | 20,000 | 20,000 |
| Debt Repayment | -20,600 | -20,600 | N/A | N/A | N/A |
| Common Stock Issued | 1,974 | 451 | 100 | 80,139 | 80,092 |
| Other Financing Activity | -1,495 | -345 | 0 | -36,386 | -36,385 |
| Financing Cash Flow | $11,479 | $106 | $100 | $63,753 | $63,707 |
| Beginning Cash Position | 104,566 | 104,566 | 104,566 | 94,846 | 94,846 |
| End Cash Position | 68,448 | 76,782 | 92,703 | 104,566 | 122,027 |
| Net Cash Flow | $-36,118 | $-27,784 | $-11,863 | $9,720 | $27,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,311 | -27,871 | -11,944 | -53,666 | -36,257 |
| Capital Expenditure | -286 | -19 | -19 | -367 | -269 |
| Free Cash Flow | -47,597 | -27,890 | -11,963 | -54,033 | -36,526 |